about
sameAs
Barrel-stave model or toroidal model? A case study on melittin pores.Comprehensive examination of mesophases formed by DMPC and DHPC mixtures.Membrane-bound ARF1 peptide: interpretation of neutron diffraction data by molecular dynamics simulation methods.Autoinsertion of soluble oligomers of Alzheimer's Abeta(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface.Temperature driven annealing of perforations in bicellar model membranes.Effect of changing the size of lipid headgroup on peptide insertion into membranesThe Observation of Highly Ordered Domains in Membranes with Cholesterol.Neutron diffraction with an excess-water cellVitamin E Circular Dichroism Studies: Insights into Conformational Changes Induced by the Solvent's PolarityThe location and behavior of alpha-tocopherol in membranes.Granular chains with soft boundaries: Slowing the transition to quasiequilibrium.Cholesterol's location in lipid bilayers.Testing High Concentrations of Membrane Active Antibiotic Chlorhexidine Via Computational Titration and Calorimetry.Molecular structures of fluid phosphatidylethanolamine bilayers obtained from simulation-to-experiment comparisons and experimental scattering density profiles.Lipid bilayer thickness determines cholesterol's location in model membranes.α-Tocopherol's Location in Membranes Is Not Affected by Their Composition.Cholesterol in bilayers with PUFA chains: doping with DMPC or POPC results in sterol reorientation and membrane-domain formation.Characterization of protein resistant, grafted methacrylate polymer layers bearing oligo(ethylene glycol) and phosphorylcholine side chains by neutron reflectometry.Location of chlorhexidine in DMPC model membranes: a neutron diffraction study.The functional significance of lipid diversity: orientation of cholesterol in bilayers is determined by lipid species.Small molecule interaction with lipid bilayers: a molecular dynamics study of chlorhexidine.The effect of fusion inhibitors on the phase behaviour of N-methylated dioleoylphosphatidylethanolamine.Oblique membrane insertion of viral fusion peptide probed by neutron diffraction.The fusion peptide of simian immunodeficiency virus and the phase behaviour of N-methylated dioleoylphosphatidylethanolamine.Molecular dynamics simulations of a mixed DOPC/DOPG bilayer.A structural study of the myristoylated N-terminus of ARF1.Tocopherol activity correlates with its location in a membrane: a new perspective on the antioxidant vitamin E.Dimyristoyl phosphatidylcholine: a remarkable exception to α-tocopherol's membrane presence.Ion distribution in multilayers of weak polyelectrolytes: A neutron reflectometry study.Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation.Cholesterol is found to reside in the center of a polyunsaturated lipid membrane.Macrocyclic Oligoesters Incorporating a Cyclotetrasiloxane Ring.Cholesterol shows preference for the interior of polyunsaturated lipid membranes.Bilayer thickness and thermal response of dimyristoylphosphatidylcholine unilamellar vesicles containing cholesterol, ergosterol and lanosterol: a small-angle neutron scattering study.Cholesterol hydroxyl group is found to reside in the center of a polyunsaturated lipid membrane.Spontaneously formed unilamellar vesicles with path-dependent size distribution.Finite-size effects in biomimetic smectic films.Finite-size effects do not reduce the repeat spacing of phospholipid multibilayer stacks on a rigid substrate.The membrane bound N-terminal domain of human adenosine diphosphate ribosylation factor-1 (ARF1).Neutron Scattering at the Intersection of Heart Health Science and Biophysics.
P50
Q28346167-F2FA9043-0A31-4636-9726-A4AF4F0BEBACQ30990937-E534AC86-FE7E-41B2-B571-802C9A42C89DQ31020739-A2AB88BA-161B-4419-AECE-D0E62E7175D3Q33260929-2AD5C07E-A860-4030-9473-7BD17B9DBC1EQ33856182-D12143B8-6D5F-4C1A-A214-F274C523AC59Q33907031-951AC2A0-DC87-4E4A-9602-397ED3BCC801Q34792593-21430992-0F85-4112-90DF-0DDA1DCA3C8FQ36273116-899F77BA-2345-49B4-8C63-0FB10F462CB4Q37539331-D7044011-2FD4-4373-B57A-2B3FEF92A5C8Q37694422-4D0FE1A2-9166-4840-A833-7C9925330001Q38562038-F93981E5-6E5C-4F25-A315-C9111800876AQ38801268-FD6E97D6-F4F4-4011-AFF1-C7B2915B8639Q38829109-90419BFC-0301-4C87-8057-89D3D7C25D4BQ39092225-1C2E7726-DAB4-4428-924F-AF6166238851Q39228184-253DFD4F-BEBA-474E-9FEE-2C0E58DE8D3BQ42688381-A4A78A45-AC5F-4BB6-8B7D-4989DE8271FCQ42952653-12379C6A-E38B-425D-803F-C0FF37C4F3CAQ43090635-E6403B2B-B79B-4019-A731-B3D91C84A603Q43111995-B659A61F-771F-47C9-AB55-7C1AB787801AQ43244983-552B6B17-21AF-4691-87E4-8CC7DCE777B5Q43758251-55756B81-EA71-451C-8DA9-F8594C1EA13FQ43978453-66C6A51D-3564-4D2C-8395-2487827436F9Q44633255-1752174B-AB0B-4461-A12E-77032D98A2DDQ44668466-6536540C-8087-43C8-BA59-1ADA4490A68AQ44793282-AABB9606-9350-4B1B-A18A-86264D2DE431Q45238284-9983A18C-12BA-4F5D-89E4-42D9803C0C65Q45280464-91758686-CEDA-48F2-9877-6BD0319511F1Q45793165-48945C08-4CA4-4C5B-B07F-FBAB0C1ED894Q46221799-584153B6-FE12-493D-BEA7-887809911637Q46279559-B21418B2-2B8A-4392-8D5E-15A11D763412Q46547999-2082B870-34F8-4F87-99DF-D3F0CCE8DA40Q46716854-3B2E452A-5F3B-405E-90B0-5C6DB92D71EAQ46853337-67E7BBE2-53C1-41EF-B431-341025F73E4EQ46874104-F8415EBB-05EE-4326-B378-4EC3C824CE16Q46906505-80361C27-4295-4B14-B6CC-DE0AF35C41A7Q47375548-D61C1FAF-70E6-44E7-A451-27072981A2ECQ47392802-BB8A54FE-2221-4A58-B15F-55D67F15F2EDQ47418250-B27B2059-23E0-48ED-AB91-4B835A772309Q47730650-6CDEFA69-3295-48EB-8A67-472E99C6D4C8Q48181410-F81AA55E-CB3D-4B09-A161-211E025639B9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thad A Harroun
@es
Thad A. Harroun
@en
Thad A. Harroun
@nl
Thad A. Harroun
@sl
type
label
Thad A Harroun
@es
Thad A. Harroun
@en
Thad A. Harroun
@nl
Thad A. Harroun
@sl
altLabel
Thad Harroun
@en
prefLabel
Thad A Harroun
@es
Thad A. Harroun
@en
Thad A. Harroun
@nl
Thad A. Harroun
@sl
P1053
C-6491-2009
P106
P108
P1153
6701589311
P21
P31
P3829
P496
0000-0001-9816-2590
P569
2000-01-01T00:00:00Z